Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$86 Mln
Revenue (TTM)
$848 Mln
Net Profit (TTM)
$80 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
6
P/B Ratio
0.6
Industry P/E
56.51
EV/EBITDA
0
Div. Yield
4.3 %
Debt to Equity
0
Book Value
$--
EPS
$7.6
Face value
--
Shares outstanding
22,296,154
CFO
CN¥659.91 Mln
EBITDA
CN¥-95.39 Mln
Net Profit
CN¥-77.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ihuman Inc (IH)
| -20.5 | -3.5 | -20.5 | -24.1 | -19.8 | -34.1 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Ihuman Inc (IH)
| 24.3 | -44.7 | 18.1 | -7.1 | -84.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ihuman Inc (IH)
|
1.7 | 86.3 | 848.0 | 106.4 | 0.0 | 11.1 | 6 | 0.6 |
| 22.8 | 8,839.9 | 29,521.0 | 1,161.0 | 0.1 | 7.8 | 83.4 | 4.5 | |
| 5.8 | 170.6 | 1,119.1 | -250.7 | -9.6 | -14.3 | -- | 0.8 | |
| 4.9 | 1,525.6 | 13,199.8 | 2,473.1 | 6.5 | 15.6 | 4 | 0.5 | |
| 8.1 | 8,461.3 | 12,149.6 | 4,288.1 | 6.7 | 11 | 13.3 | 1.5 | |
| 40.2 | 7,868.8 | 11,120.8 | 923.8 | 22.6 | 3.7 | 62.3 | 2.2 | |
| 5.9 | 908.8 | 10,084.7 | 787.0 | 12.7 | 7 | 8.3 | 0.6 | |
| 13.5 | 6,447.1 | 8,042.3 | 2,660.8 | 4.6 | 15.2 | 15.7 | 2.2 | |
| 1.9 | 23.4 | 541.9 | 71.6 | -54.0 | 8.2 | 1.1 | 0.1 | |
| 9.4 | 1,180.2 | 5,909.0 | 107.4 | 2.8 | -5.2 | 58.1 | 60.1 |
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China and internationally. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman... ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and iHuman Chinese Reading; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo series; and Aha World and Aha Makeover. It also provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity; and Cosmicrew, a 3D comedic adventure animation series. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China. Address: Building A, Beijing, China, 100102 Read more
CFO & Director
Ms. Weiwei Wang
CFO & Director
Ms. Weiwei Wang
Headquarters
Beijing
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Ihuman Inc (IH) is $1.67 (NYSE) as of 02-Apr-2026 11:58 EDT. Ihuman Inc (IH) has given a return of -19.82% in the last 3 years.
The P/E ratio of Ihuman Inc (IH) is 6.00 times as on 31-Mar-2026, a 89 discount to its peers’ median range of 56.51 times.
The P/B ratio of Ihuman Inc (IH) is 0.60 times as on 31-Mar-2026, a 87 discount to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
4.46
|
0.46
|
|
2023
|
0.93
|
0.18
|
|
2022
|
1.30
|
0.18
|
|
2021
|
-4.03
|
0.25
|
|
2020
|
-25.14
|
1.47
|
The 52-week high and low of Ihuman Inc (IH) are Rs 3.60 and Rs 1.59 as of 02-Apr-2026.
Ihuman Inc (IH) has a market capitalisation of $ 86 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Ihuman Inc (IH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.08
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.